definiens: E - EPAProducts ", as further defined below ), from Nisshin to [COMPANY], for the purposes of conducting clinical trials within the CNS ( Central Nervous System ) field, to provide the Products to [COMPANY] to be used as the active pharmaceutical ingredient for the Drug and for submission to regulatory bodies for approval . ( The 1999 Agreement was originally made and entered into between Nisshin Flour Milling Co., Ltd., a Japanese corporation, the parent company of Nisshin at that time, and Laxdale Limited, a Scottish company, now known as [COMPANY] Neuroscience Limited due to the corporate take - over closed on October 8, 2004 by [COMPANY] Corporation pic, and the duties and obligations under the 1999 Agreement were transferred by assignment to the Parties, by Nisshin Flour Milling Co., Ltd. to Nisshin on July 2,2001 ; and by [COMPANY] Neuroscience Limited to [COMPANY] on November 15, 2005 . ) WHEREAS, upon [COMPANY] 's request and after discussion with [COMPANY], Nisshin agreed to extend the 1999 Agreement for a further three years in 2005, which resulted in the execution of that certain agreement of November 15, 2005, under which the supply of the Products was extended until June 6,2008, as well as Nisshin agreed to cooperate with [COMPANY], including but not limited to, for dealing with FDA inspections